HSBC Holdings
HCAT icon

HSBC Holdings’s Health Catalyst HCAT Stock Holding History

HSBC Holdings’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123K Buy
98,868
+17,332
+21% +$32.6K ﹤0.01% 2724
2025
Q4 		$192K Hold
81,536
– – ﹤0.01% 2697
2025
Q3 		$234K Buy
81,536
+1,273
+2% +$4.36K ﹤0.01% 2424
2025
Q2 		$305K Sell
80,263
-40,104
-33% -$158K ﹤0.01% 2426
2025
Q1 		$537K Buy
120,367
+46,580
+63% +$246K ﹤0.01% 2043
2024
Q4 		$522K Sell
73,787
-473
-0.6% -$3.77K ﹤0.01% 2153
2024
Q3 		$610K Sell
74,260
-4,067
-5% -$29.4K ﹤0.01% 1912
2024
Q2 		$479K Buy
78,327
+20,672
+36% +$133K ﹤0.01% 1987
2024
Q1 		$434K Buy
57,655
+5,572
+11% +$50.9K ﹤0.01% 2176
2023
Q4 		$487K Buy
52,083
+10,663
+26% +$87.1K ﹤0.01% 2058
2023
Q3 		$411K Buy
41,420
+30,127
+267% +$360K ﹤0.01% 2065
2023
Q2 		$142K Buy
+11,293
New +$134K ﹤0.01% 2386
2022
Q2 		– Sell
-8,622
Closed -$228K – 3323
2022
Q1 		$228K Sell
8,622
-17,660
-67% -$501K ﹤0.01% 2930
2021
Q4 		$1.04M Sell
26,282
-1,591
-6% -$72.5K ﹤0.01% 2017
2021
Q3 		$1.39M Buy
27,873
+21,797
+359% +$1.19M ﹤0.01% 1712
2021
Q2 		$339K Buy
+6,076
New +$324K ﹤0.01% 2433

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's HCAT Position: Q1 2026 in Review

HSBC Holdings increased its Health Catalyst (HCAT) stake by 21% in Q1 2026, buying an estimated $32.6K and bringing the position to 98,868 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

HSBC Holdings first reported a position in HCAT in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.39M in Q3 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • HSBC Holdings held 98,868 shares of Health Catalyst worth $123K as of Q1 2026.
  • HSBC Holdings bought 17,332 Health Catalyst shares in Q1 2026, an estimated $32.6K.
  • Health Catalyst made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2724 holding.
  • HSBC Holdings first reported a position in Health Catalyst in Q2 2021 and has held it in 16 quarters since.
  • HSBC Holdings's Health Catalyst position peaked at $1.39M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.